TaylorMade's new P·790 irons are designed for golfers who want the look of a player's iron with the forgiveness of a game-improvement club. The updated clubs feature a new forged face that is thinner ...

Golf Pride couldn’t have asked for a better few weeks leading up to the release of its newest release of its new update to an ...

Leerink Partners cut shares of 10x Genomics (NASDAQ:TXG – Free Report ... RA Capital Management L.P. bought a new position in 10x Genomics in the fourth quarter valued at approximately $47,092,000.

For the quarter ended December 2024, 10x Genomics (TXG) reported revenue of $165.02 ... 23.5% over the past month versus the Zacks S&P 500 composite's +4.3% change. The stock currently has a ...

A number of institutional investors and hedge funds have recently modified their holdings of TXG. RA Capital Management L.P. purchased a new position in shares of 10x Genomics in the fourth ...

It’s hard to talk about TaylorMade’s P·790 without acknowledging the seismic shift it caused in the iron market. Before the ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results beating Wall Street’s revenue expectations , but sales fell by 10.3% year on year to $165 million. On the other hand, ...

CEO Serge Saxonov highlighted strong growth across platforms, with total revenue for Q4 2023 reaching $184 million, an 18% increase year-over-year. Spatial products contributed significantly, with ...

10x Genomics posted a Q4 EPS loss of $(0.40), missing the $(0.30) estimate. The company’s 2025 sales guidance of $610M-$630M is below the $631.14M consensus. Get two weeks of free access to pro ...